Fairmount Funds Management Llc
Director at Cogent Biosciences, Inc. (COGT); Director at Spyre Therapeutics, Inc. (SYRE)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $770M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 23SEC | SYRESpyre Therapeutics, Inc. | Sell | 4,684,781 | $85.31 | $400M | -6.3% |
| Mar 31SEC | COGTCogent Biosciences, Inc. | Sell | 7,000,0005,503,418 held (−56%) | $34.66 | $243M | -14.8% |
| Jan 22SEC | COGTCogent Biosciences, Inc. | Sell | 3,500,0005,503,418 held (−39%) | $36.40 | $127M | -18.9% |
- Sell
Director Fairmount Funds Management Llc sold $243M of COGT at $34.66 — cuts the stake by 56%.
- Sell
Director Fairmount Funds Management Llc sold $127M of COGT at $36.40 — cuts the stake by 39%.